JPH0124769B2 - - Google Patents

Info

Publication number
JPH0124769B2
JPH0124769B2 JP55062357A JP6235780A JPH0124769B2 JP H0124769 B2 JPH0124769 B2 JP H0124769B2 JP 55062357 A JP55062357 A JP 55062357A JP 6235780 A JP6235780 A JP 6235780A JP H0124769 B2 JPH0124769 B2 JP H0124769B2
Authority
JP
Japan
Prior art keywords
virus
cells
culture
influenza
influenza virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP55062357A
Other languages
English (en)
Japanese (ja)
Other versions
JPS55153723A (en
Inventor
Kei Buraun Kaaren
Shii Suchuwaato Richaado
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Corp
Original Assignee
Mobay Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21904398&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JPH0124769(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Mobay Corp filed Critical Mobay Corp
Publication of JPS55153723A publication Critical patent/JPS55153723A/ja
Publication of JPH0124769B2 publication Critical patent/JPH0124769B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
JP6235780A 1979-05-15 1980-05-13 Manufacture of influenza virus vaccine in liquid cell culture Granted JPS55153723A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3923679A 1979-05-15 1979-05-15

Publications (2)

Publication Number Publication Date
JPS55153723A JPS55153723A (en) 1980-11-29
JPH0124769B2 true JPH0124769B2 (en:Method) 1989-05-15

Family

ID=21904398

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6235780A Granted JPS55153723A (en) 1979-05-15 1980-05-13 Manufacture of influenza virus vaccine in liquid cell culture

Country Status (13)

Country Link
EP (1) EP0019218B2 (en:Method)
JP (1) JPS55153723A (en:Method)
AR (1) AR220838A1 (en:Method)
AT (1) ATE16454T1 (en:Method)
AU (1) AU535804B2 (en:Method)
CA (1) CA1122527A (en:Method)
DE (1) DE3071225D1 (en:Method)
DK (1) DK154749C (en:Method)
ES (1) ES8104405A1 (en:Method)
IL (1) IL60063A0 (en:Method)
NO (1) NO801443L (en:Method)
RO (1) RO79525B (en:Method)
YU (1) YU41923B (en:Method)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6146873A (en) * 1994-11-10 2000-11-14 Baxter Aktiengesellschaft Production of orthomyxoviruses in monkey kidney cells using protein-free media
DE69535940D1 (de) * 1994-11-10 2009-06-04 Baxter Healthcare Sa Verfahren zur Herstellung von biologischen Produkten in Protein-freiem Kultur
US5698433A (en) * 1994-11-10 1997-12-16 Immuno Ag Method for producing influenza virus and vaccine
US5753489A (en) * 1994-11-10 1998-05-19 Immuno Ag Method for producing viruses and vaccines in serum-free culture
AU694592B2 (en) * 1994-11-16 1998-07-23 St. Jude Children's Research Hospital Novel replication process
DE19612966B4 (de) 1996-04-01 2009-12-10 Novartis Vaccines And Diagnostics Gmbh & Co. Kg MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren
DE19612967A1 (de) * 1996-04-01 1997-10-02 Behringwerke Ag Verfahren zur Vermehrung von Influenzaviren in Zellkultur, sowie die durch das Verfahren erhältlichen Influenzaviren
DE10144906B4 (de) 2001-09-12 2013-11-28 Novartis Vaccines And Diagnostics Gmbh Verfahren zur großtechnischen Herstellung von Impfstoffen
US6830917B2 (en) 2001-12-10 2004-12-14 Baxter Healthcare S.A. Method of isolation and purification of trypsin from pronase protease and use thereof
US20090004222A1 (en) 2004-11-03 2009-01-01 O'hagan Derek Influenza Vaccination
WO2007132763A1 (ja) * 2006-05-11 2007-11-22 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute インフルエンザウイルスの増殖方法
US8506966B2 (en) 2008-02-22 2013-08-13 Novartis Ag Adjuvanted influenza vaccines for pediatric use
TW201012930A (en) * 2008-06-16 2010-04-01 Intervet Int Bv Method of replicating viruses in suspension
EA023662B1 (ru) 2009-02-10 2016-06-30 Новартис Аг Вакцины против гриппа со сниженным количеством сквалена

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2262962B1 (en:Method) * 1974-03-05 1977-11-04 Science Union & Cie

Also Published As

Publication number Publication date
YU126580A (en) 1983-12-31
AU5824480A (en) 1980-11-20
IL60063A0 (en) 1980-07-31
EP0019218A3 (en) 1981-03-25
EP0019218B1 (de) 1985-11-13
AR220838A1 (es) 1980-11-28
DK154749B (da) 1988-12-19
DE3071225D1 (en) 1985-12-19
YU41923B (en) 1988-02-29
AU535804B2 (en) 1984-04-05
EP0019218A2 (de) 1980-11-26
DK212580A (da) 1980-11-16
JPS55153723A (en) 1980-11-29
ES491517A0 (es) 1981-04-01
CA1122527A (en) 1982-04-27
ATE16454T1 (de) 1985-11-15
RO79525B (ro) 1984-09-30
ES8104405A1 (es) 1981-04-01
EP0019218B2 (de) 1995-03-01
NO801443L (no) 1980-11-17
RO79525A (ro) 1984-07-17
DK154749C (da) 1989-05-16

Similar Documents

Publication Publication Date Title
US4500513A (en) Influenza vaccine production in liquid cell culture
JPH0124769B2 (en:Method)
US4224412A (en) Living virus culture vaccine against canine distemper and method of preparing same
JP2000507825A (ja) 細胞培養におけるインフルエンザウイルスの複製の方法、および本方法によって入手可能なインフルエンザウイルス
CA1174599A (en) Herpes simplex type i subunit vaccine
HU183765B (en) Process for producing lyophilized vaccine against duck hepatitis
CN105688202A (zh) 一种乙型脑炎疫苗组合物及其制备方法
USRE33164E (en) Influenza vaccine production in liquid cell culture
US4320115A (en) Rabies virus vaccine
US4571386A (en) Feline infectious peritonitis vaccine
Reed Persistent respiratory virus infection in tracheal organ cultures
WO2009004641A2 (en) Adaptation of pitman moore strain of rabies virus to primary chick embryo fibroblast cell cultures
CN112080478B (zh) 一种h5亚型禽流感病毒的高效增殖方法及应用
RU2142816C1 (ru) Способ получения антигерпетической вакцины и лекарственная форма на ее основе
Crick The vaccination of man and other animals against rabies
JP3043353B2 (ja) ワクチン
US3585108A (en) Transmissible gastroenteritis vaccines and methods of producing the same
US3098011A (en) Process of producing a vaccine against distemper
JP2007068401A (ja) 西ナイルウイルスワクチン
US3255080A (en) Live rabies virus vaccine and method for the production thereof
KR830002615B1 (ko) 세포배양액내에서 인플루엔자 왁진의 제조방법
US3629396A (en) Avian encephalomyelitis vaccine
Toba et al. Role of interferon in enhanced replication of Newcastle disease virus in swine cells infected with hog cholera virus
El‐Zein et al. Preparation and testing of a goat pox vaccine from a pathogenic field isolate attenuated in cell culture
RU2108385C1 (ru) Аттенуированный штамм вируса чумы плотоядных virus pestis carnivorum